The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome
- PMID: 26400629
- PMCID: PMC4737239
- DOI: 10.1002/ajmg.b.32378
The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome
Abstract
Background: Although attention deficit-hyperactivity disorder (ADHD) is the most prevalent psychiatric disorder in children with 22q11.2DS, it remains unclear whether its clinical presentation is similar to that in children with idiopathic ADHD. The aim of this study is to compare the ADHD phenotype in children with and without 22q11.2DS by examining ADHD symptom scores, patterns of psychiatric comorbidity, IQ and gender distribution.
Methods: Forty-four children with 22q11.2DS and ADHD (mean age = 9.6), 600 clinic children (mean age = 10.8) and 77 children with ADHD from a population cohort (mean age = 10.8) participated in the study. Psychopathology was assessed using parent-report research diagnostic instruments.
Results: There was a higher proportion of females in the 22q11.2DS ADHD sample in relation to the clinical sample (χ(2) = 18.2, P < 0.001). The 22q11.2DS group showed a higher rate of ADHD inattentive subtype (χ(2) = 114.76, P < 0.001), and fewer hyperactive-impulsive symptoms compared to the clinical group (z = 8.43, P < 0.001). The 22q11.2DS ADHD group parents reported fewer oppositional defiant disorder/conduct disorder symptoms (z = 6.33, P < 0.001) and a higher rate of generalized anxiety disorder (χ(2) = 4.56, P = 0.03) in relation to the clinical group. Two percent of the 22q11.2 DS ADHD sample had received ADHD treatment. The results were similar when the 22q11.2 ADHD group was compared to the population cohort ADHD group.
Conclusions: The clinical presentation of ADHD and patterns of co-morbidity in 22q11.2DS is different from that in idiopathic ADHD. This could lead to clinical under-recognition of ADHD in this group. Examining psychopathology in 22q11.2DS can provide insights into the genetic origins of psychiatric problems with implications beyond the 22q11.2DS population.
Keywords: 22q11.2DS; ADHD; ALSPAC; children.
© 2015 Wiley Periodicals, Inc.
Figures
Similar articles
-
Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.Schizophr Bull. 2018 Jun 6;44(4):824-833. doi: 10.1093/schbul/sbx113. Schizophr Bull. 2018. PMID: 29040797 Free PMC article.
-
Developmental coordination disorder, psychopathology and IQ in 22q11.2 deletion syndrome.Br J Psychiatry. 2018 Jan;212(1):27-33. doi: 10.1192/bjp.2017.6. Br J Psychiatry. 2018. PMID: 29433607 Free PMC article.
-
Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome.Schizophr Res. 2019 Feb;204:320-325. doi: 10.1016/j.schres.2018.07.044. Epub 2018 Aug 7. Schizophr Res. 2019. PMID: 30093352 Free PMC article.
-
[Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].Encephale. 2015 Jun;41(3):266-73. doi: 10.1016/j.encep.2014.10.005. Epub 2014 Dec 16. Encephale. 2015. PMID: 25523123 Review. French.
-
Developmental trajectories in 22q11.2 deletion.Am J Med Genet C Semin Med Genet. 2015 Jun;169(2):172-81. doi: 10.1002/ajmg.c.31435. Epub 2015 May 18. Am J Med Genet C Semin Med Genet. 2015. PMID: 25989227 Free PMC article. Review.
Cited by
-
Environmental Influences on the Relation between the 22q11.2 Deletion Syndrome and Mental Health: A Literature Review.Genes (Basel). 2022 Nov 2;13(11):2003. doi: 10.3390/genes13112003. Genes (Basel). 2022. PMID: 36360240 Free PMC article. Review.
-
Selective Effects of Methylphenidate on Attention and Inhibition in 22q11.2 Deletion Syndrome: Results From a Clinical Trial.Int J Neuropsychopharmacol. 2022 Mar 17;25(3):215-225. doi: 10.1093/ijnp/pyab057. Int J Neuropsychopharmacol. 2022. PMID: 34453525 Free PMC article. Clinical Trial.
-
Cross-sectional and longitudinal findings in patients with proximal 22q11.2 duplication: A retrospective chart study.Am J Med Genet A. 2022 Jan;188(1):46-57. doi: 10.1002/ajmg.a.62487. Epub 2021 Sep 7. Am J Med Genet A. 2022. PMID: 34491614 Free PMC article.
-
Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.Schizophr Bull. 2017 Sep 1;43(5):1079-1089. doi: 10.1093/schbul/sbx005. Schizophr Bull. 2017. PMID: 28204757 Free PMC article.
-
A comprehensive overview of neuropsychiatric symptoms in adolescents with 22q11.2 deletion syndrome.J Intellect Disabil Res. 2025 Feb;69(2):113-126. doi: 10.1111/jir.13196. Epub 2024 Oct 22. J Intellect Disabil Res. 2025. PMID: 39438700 Free PMC article.
References
-
- Angold A, Prendergast M, Cox A, Harrington R, Simonoff E, Rutter M. 1995. The child and adolescent psychiatric assessment (CAPA). Psychol Med 25(4):739–753. - PubMed
-
- Antshel KM, Faraone SV, Fremont W, Monuteaux MC, Kates WR, Doyle A, Mick E, Biederman J. 2007. Comparing ADHD in velocardiofacial syndrome to idiopathic ADHD: A preliminary study. J Atten Disord 11(1):64–73. - PubMed
-
- DuPaul GJ, Gormley MJ, Laracy SD. 2013. Comorbidity of LD and ADHD: Implications of DSM‐5 for assessment and treatment. J Learn Disabil 46(1):43–51. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical